Week of June 25 - 01, 2017


Lung Cancer Webucation

Updated for 2017! Our webucation program guides you through diagnosis, treatment and coping with lung cancer.

Feeding Tubes: The Basics

Information about feeding tubes, which are used to supply nutrition when an individual is unable to eat or absorb nutrients through the gastrointestinal (GI) tract.

Midostaurin (Rydapt ®)

Midostaurin (Rydapt ®) is a kinase inhibitor used in the treatment of AML that is FLT3 mutation positive and mast cell leukemia. 

OncoLink at PTCOG

OncoLink coverage of sessions at the 56th Annual Conference of the Particle Therapy Co-operative Group in Japan.

Brigatinib (Alunbrig™)

Brigatinib (Alunbrig ™) is a kinase inhibitor used to treat patients with anaplastic lymphoma kinase (ALK)- positive metastatic non-small cell lung cancer.  

Durvalumab (Imfinzi™)

Durvalumab is a monoclonal antibody, immune therapy used in the treatment of metastatic urothelial cancer.

Niraparib (Zejula™)

Niraparib is a PARP inhibitor used in the treatment of ovarian, fallopian tube, endometrial and primary peritoneal cancers.

Avelumab (Bavenicio ®)

Avelumab (Bavenicio ®) is a programmed death ligand-1 (PD-L1) blocking antibody used in the treatment of Merkel cell carcinoma. 

Telotristat (Xermelo™)

Telotristat (Xermelo™) is a tryptophan hydroxylase inhibitor used to treat diarrhea related to carcinoid syndrome.

Ribociclib (Kisqali®)

Ribociclib (Kisquali®) is used in the treatment of hormone receptor positive, HER2 negative, advanced or metastatic breast cancer in post-menopausal women. 

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
R
S
T
U
V
X
Y
Z
#
 
A
B
C
E
F
G
H
K
L
M
N
O
P
R
S
T
U
V
 
 
Manténgase informado con las últimas informaciones de OncoLink!   Suscribirse a OncoLink eNews
Ver nuestros archivos de boletines